Company Overview and News


Add POXEL
to your dashboard

Headline News

Daily, Long-Acting Oral Insulin Tablet Provides Comparable Glycemic Control to Insulin Glargine Injection in Patients with Type 2 Diabetes

2017-06-13 prnewswire
SAN DIEGO , June 13, 2017 /PRNewswire-USNewswire/ -- A long-acting, oral insulin tablet has been found to safely improve glycemic control as effectively as the common, injected insulin glargine in people with Type 2 diabetes, according to the study, "Efficacy and Safety of Oral Basal Insulin: Eight-Week Feasibility Study in People with Type 2 Diabetes (T2DM)," presented today at the American Diabetes Association's 77th Scientific Sessions® at the San Diego Convention Center.

Poxel Rockets After Diabetes Med Hits Goals in Mid-Stage Study

2017-05-04 biospace
LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat metabolic diseases, including type 2 diabetes, announced today positive top line Phase 2b data results for Imeglimin for the treatment of type 2 diabetes in Japan.

BRIEF-Nokia expands patent litigation against Apple in Asia, Europe and U.S.

2016-12-22 feeds.reuters
* Nokia -"filed further complaints alleging that apple products infringe a number of nokia patents, expanding its litigation originally announced on dec 21" Source text for Eikon: Further company coverage:

BRIEF-Basic Energy Services to continue listing new shares of common stock

2016-12-22 feeds.reuters
* Basic Energy Services Inc. to continue listing new shares of common stock and resume trading under ticker "BAS" following emergence from chapter 11 reorganization

UPDATE 1-U.S. 30-year mortgage rates rise to highest since 2014 - Freddie Mac

2016-12-22 reuters
* Net income for fiscal Q4 ended september 30, 2016 was approximately $1 million compared to a net loss of approximately $1.3 million-SEC filing

BRIEF-Poxel SA says CFO Eric Massou resigned

2016-12-22 feeds.reuters
* Poxel SA says Poxel has identified a new CFO, and an announcement will be made during Q1 of 2017 Source text for Eikon: Further company coverage:

BRIEF-Luxottica renews Ralph Lauren licence accord for 10 years

2016-12-22 feeds.reuters
* Renews licence agreement with Ralph Lauren until March 31, 2027 Further company coverage: (Reporting by Milan newsroom)

BRIEF-Nokia esays xpands patent litigation against Apple in Asia, Europe and the U.S.

2016-12-22 feeds.reuters
* Nokia corp says has filed further complaints alleging that apple products infringe a number of Nokia patents, expanding its litigation originally announced on december 21.

BRIEF-Gee Group Q4 revenue rose 75 percent to $21.8 million

2016-12-22 feeds.reuters
* Net income for fiscal Q4 ended september 30, 2016 was approximately $1 million compared to a net loss of approximately $1.3 million-SEC filing

Poxel completes patient enrollment for diabetes drug phase IIb trials in Japan

2016-07-01 biospectrumasia
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission